XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 11,484 $ 11,479 $ 12,440
Cost of sales 7,360 7,798 8,289
Gross profit 4,124 3,681 4,151
Research and development expenses 671 636 603
Selling and administrative expenses 1,995 1,787 1,768
Restructuring and other charges 29 68 12
Amortization of acquisition-related intangibles 610 680 727
Impairment of goodwill 64 2,623 2,250
Impairment of long-lived assets 0 0 120
Gains on sale of assets (11) (3) (3)
Operating profit (loss) 766 (2,110) (1,326)
Interest expense 305 380 336
(Gains) losses on business disposals (346) 23 (11)
Loss on assets classified as held for sale 347 0 0
Other expense (income), net 182 5 (26)
Income (loss) before taxes 278 (2,518) (1,625)
Provision for income taxes 31 45 239
Net income (loss) 247 (2,563) (1,864)
Net income attributable to non-controlling interest 4 4 7
Net income available to IFF common shareholders 243 (2,567) (1,871)
Other comprehensive income (loss), after tax:      
Foreign currency translation adjustments (774) 414 (933)
Gains (losses) on derivatives qualifying as hedges (3) 0 0
Pension and postretirement liability adjustment 146 (112) 158
Other comprehensive income (loss) (631) 302 (775)
Comprehensive loss (384) (2,261) (2,639)
Comprehensive loss attributable to IFF shareholders $ (388) $ (2,265) $ (2,646)
Net income per share - basic (in dollars per share) $ 0.95 $ (10.05) $ (7.32)
Net income per share - diluted (in dollars per share) $ 0.95 $ (10.05) $ (7.32)
Average number of shares outstanding - basic (in shares) 256 255 255
Average number of shares outstanding - diluted (in shares) 256 255 255